Skip to main content
. 2019 Jan 13;6(6):1801847. doi: 10.1002/advs.201801847

Figure 10.

Figure 10

a) Dual immunotherapy nanoparticle (DINP) conjugated with aPD‐1 and aOX40 bind to its target proteins simultaneously. b) DINP improves the efficacy of combination immunotherapy in vivo. Reproduced with permission.161 Copyright 2018, Wiley.